Syphilisinfektion im HNO-Bereich

Zusammenfassung

Die Anzahl der gemeldeten Syphilis-Fälle steigt seit Jahren an. Die sexuell übertragbare Erkrankung wird durch die Spirochäte Treponema pallidum Subspezies pallidum verursacht und verläuft hierbei in verschiedenen Stadien. In allen Stadien können hierbei Symptome im HNO-Bereich auftreten. Hierdurch ist bei passenden Symptomen eine Syphilis-Infektion als Differenzialdiagnose vom HNO-Arzt stets zu bedenken. So ist bei zunehmendem oralem Geschlechtsverkehr der Primäraffekt/harter Schanker zunehmend häufig im Mundraum zu beobachten. Zudem können Symptome nicht nur im Mundraum, sondern auch im Bereich des Ohrs, der Nase, des Larynx sowie auch zervikal und fazial auftreten. Die Diagnose wird hierbei über den direkten Erregernachweis oder über einen serologischen Nachweis gesichert. Die Spirochäte ist nicht kultivierbar. Der therapeutische Goldstandard ist die Gabe von Benzathin-Penicillin G oder Procain-Penicillin G. Als Alternative stehen Doxycyclin, Makrolide oder Ceftriaxon zur Verfügung. Bei einer Innenohr- oder Hirnnervenbeteiligung ist die zusätzliche Gabe eines Glukokortikoids zu empfehlen. Vor Durchführung der antibiotischen Therapie ist der Patient über die Möglichkeit einer Jarisch-Herxheimer-Reaktion aufzuklären. Bei einer Syphilis-Infektion ist stets eine kollegiale Zusammenarbeit mit den Venerologen zu empfehlen, sodass eine effektive und umfassende Diagnostik und Therapie erfolgen kann.

Abstract

The number of reported cases of syphilis has been increasing for years. The sexually transmitted disease is caused by the spirochete Treponema pallidum subspecies pallidum and progresses in different stages. Symptoms in the ENT area can occur in all stages. This means that a syphilis infection should always be considered by the ENT doctor as a differential diagnosis if the symptoms are suitable. Thus, with increasing oral sexual intercourse, the primary effect/hard chancre is more often observed in the oral cavity. In addition, symptoms can occur not only in the oral cavity, but also in the ear, nose, larynx, cervical and facial regions. The diagnosis is confirmed by direct pathogen detection or by serological detection. The spirochete cannot be cultivated. The therapeutic gold standard is the administration of benzathine penicillin G or procaine penicillin G. Doxycycline, macrolides or ceftriaxone are available as alternatives. In case of inner ear or cranial nerve involvement, the additional administration of a glucocorticoid is recommended. Before antibiotic therapy is administered, the patient must be informed about the possibility of a Jarisch-Herxheimer reaction. In cases of a syphilis infection, a collegial cooperation with the venereologists is always recommended so that an effective and comprehensive diagnosis and therapy can be carried out.

Schlüsselwörter

Syphilis - Lues - sexuell übertragbare Erkrankung - Infektionserkrankung - Treponema pallidum

Keywords

syphilis - lues - STI - STD - sexually transmitted disease - sexually transmitted infection - treponema pallidum

Publication History

Received: 20 May 2021

Accepted after revision: 18 March 2022

Article published online:
08 April 2022

• Literatur

• 1 Lautenschlager S. Diagnosis of syphilis: Clinical and laboratory problems. JDDG – Journal of the German Society of Dermatology 2006; 4: 1058-1075
• 2 LaFond RE, Lukehart SA. Biological Basis for Syphilis. Clinical Microbiology Reviews 2006; 19: 29-49
• 3 Robert Koch Institut. Epidemiologisches Bulletin. In: . Epidemiologisches Bulletin; 2018: 493-508
• 4 Hook EW, Peeling RW. Syphilis Control – A Continuing Challenge. New England Journal of Medicine 2004; 351: 122-124
• 5 Kojima N, Klausner JD. An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep 2018; 5: 24-38
• 6 Petty-Saphon N, Brady M, Cullen G. et al. A proposal for changes to the European Union syphilis surveillance case definition using evidence from evaluations in Ireland. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2019; 24: 1-6
• 7 Cohen SE, Ng RAC, Katz KA. et al. Repeat syphilis among men who have sex with men in California 2002–2006: Implications for syphilis elimination efforts. American Journal of Public Health 2012; 102: 2002-2006
• 8 Lautenschlager S. Sexually transmitted infections in Switzerland: Return of the classics. Dermatology 2005; 210: 134-142
• 9 Di Carlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997; 25: 292-298
• 10 Schöfer H. Syphilis: Klinik der Treponema-pallidum-infektion. Hautarzt 2004; 55: 112-119
• 11 Lacey HB, Higgins SP, Graham D. An outbreak of early syphilis: Cases from North Manchester general hospital. Sexually Transmitted Infections 2001; 77: 311-313
• 12 Ghanem KG. Neurosyphilis: A historical perspective and review. CNS Neuroscience and Therapeutics 2010; 16: 157-168
• 13 Clement ME, Okeke NL, Hicks CB. Treatment of Syphilis a systematic Review. JAMA 2014; 312: 1905-1917
• 14 Butterfield R. Syphilis. Pediatrics in Review 2014; 35: 212-213
• 15 Leuci S, Martina S, Adamo D. et al. Oral Syphilis: A retrospective analysis of 12 cases and a review of the literature. Oral Diseases 2013; 19: 738-746
• 16 Fukuda H, Takahashi M, Kato K. et al. Multiple primary syphilis on the lip, nipple-areola and penis: An immunohistochemical examination of Treponema pallidum localization using an anti-T. pallidum antibody. Journal of Dermatology 2015; 42: 515-517
• 17 De Andrade RS, De Freitas EM, Rocha BA. et al. Oral findings in secondary syphilis. Medicina Oral Patologia Oral y Cirugia Bucal 2018; 23: e138-e143
• 18 Leão JC, Gueiros LA, Porter SR. Oral manifestations of syphilis. Clinics 2006; 61: 161-166
• 19 Ficarra G, Carlos R. Syphilis: The renaissance of an old disease with oral implications. Head and Neck Pathology 2009; 3: 195-206
• 20 Singh AE, Romanowski B. Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features. Clinical Microbiology Reviews 1999; 12: 187-209
• 21 Neville BW, Damm DD, Allen CM. et al. Oral and Maxillofacial Pathology. Fourth Edi. St. Louis: Elsevier; 2015
• 22 Trieger N, Ship II, Taylor GW. et al. Cirrhosis and other predisposing factors in carcinoma of the tongue. Cancer 1958; 11: 357-362
• 23 Meyer I, Abbey LM. The relationship of syphilis to primary carcinoma of the tongue. Northwest dentistry 1970; 30: 678-681
• 24 Dickenson AJ, Currie WJR, Avery BS. Screening for syphilis in patients with carcinoma of the tongue. British Journal of Oral and Maxillofacial Surgery 1995; 33: 319-320
• 25 Lahav G, Lahav Y, Ciobotaro P. et al. Laryngeal Syphilis. Archives of Otolaryngology Head and Neck Surgery 2011; 137: 294-297
• 26 Syphilis of the Throat and Nose-II. The Hospital 1908; 44: 179
• 27 Ramstad T, Traaholt L. Destruction of the soft palate and nose by tertiary „benign“ syphilis. A case report. Journal of Oral Rehabilitation 1980; 7: 111-115
• 28 Masege S, Karstaedt A. A rare case of a chronic syphilitic gumma in a man infected with human immunodeficiency virus. The Journal of Laryngology & Otology 2014; 128: 557-560
• 29 Morrison AW. On syphilis and the ear – an otologist’s view. Genitourinary Medicine 1992; 68: 420-422
• 30 Sardana K, Goel K. Nasal septal ulceration. Clinics in Dermatology 2014; 32: 817-826
• 31 Syphilis of the Throat and Nose-I. The Hospital 1908; 44: 125
• 32 Pan X, Zhu X, Qingdi QL. Syphilis manifesting as a nasopharyngeal carcinoma with cervical lymphadenopathy: A case report. Experimental and Therapeutic Medicine 2012; 3: 1023-1025
• 33 Merritt HH, Moore M. Acute syphilitic meningitis. Medicine 1935; 14: 119-183
• 34 Piura Y, Mina Y, Aizenstein O. et al. Neurosyphilis presenting as cranial nerve palsy, an entity which is easy to miss. BMJ Case Reports 2019; 12: 2018-2020
• 35 Young AS, Carroll AS, Welgampola MS. et al. Acute unilateral peripheral vestibulopathy in neurosyphilis. Journal of the Neurological Sciences 2017; 378: 55-58
• 36 Hong JH, Lee HY, Lim MK. et al. Meningovascular and Spinal form of Neurosyphilis Presenting as Multiple Cranial Nerve Palsy, Cerebral Infarction and Meningomyelitis in a Human Immunodeficiency Virus Negative-Patient: MR Imaging Features. Journal of the Korean Society of Magnetic Resonance in Medicine 2014; 18: 263-268
• 37 Ting CH, Wang CW, Lee JT. et al. Bilateral facial nerve palsy as the sole initial symptom of syphilis: A case report. Canadian Journal of Emergency Medicine 2015; 17: 576-581
• 38 Maeda T, Yoshizawa S, Hirayama T. et al. Neurosyphilis mimicking Ramsay Hunt syndrome. Journal of Nippon Medical School 2015; 82: 254-256
• 39 Alqahtani S. Acute cranial neuropathies heralding neurosyphilis in a human immunodeficiency virus-infected patient. American Journal of Case Reports 2014; 15: 411-415
• 40 Smith MM, Anderson JC. Neurosyphilis as a cause of facial and vestibulocochlear nerve dysfunction: MR imaging features. American Journal of Neuroradiology 2000; 21: 1673-1675
• 41 Kılıç Çoban E, Aldan MA, Gez S. et al. A Case of Neurosyphilis Presenting with Multiple Cranial Neuropathy. Turkish Journal Of Neurology 2016; 22: 127-129
• 42 Eliott D, Papaliodis GN, Durand ML. Case 20–2016: A 50-year-old man with cloudy vision, hearing loss, and unsteadiness. New England Journal of Medicine 2016; 374: 2586-2593
• 43 Sonne JE, Zeifer B, Linstrom C. Manifestations of otosyphilis as visualized with computed tomography. Otology and Neurotology 2002; 23: 806-807
• 44 Darmstadt GL, Harris JP. Luetic Hearing Loss: Clinical Presentation, Diagnosis, and Treatment. American journal of otolaryngology 1989; 10: 410-421
• 45 García-Berrocal JR, Górriz C, Ramírez-Camacho R. et al. Otosyphilis mimics immune disorders of the inner ear. Acta Oto-Laryngologica 2006; 126: 679-684
• 46 Hart G. Syphilis tests in diagnostic and therapeutic decision making. Annals of internal medicine 1986; 104: 368-376
• 47 Gayet-Ageron A, Combescure C, Lautenschlager S. et al. Comparison of diagnostic accuracy of PCR targeting the 47-kilodalton protein membrane gene of Treponema pallidum and PCR targeting the DNA Polymerase I gene: systematic review and meta-analysis. Journal of clinical microbiology 2015; 53: 3522-3529
• 48 Buder S, Schöfer H, Meyer T. et al. Bakterielle sexuell übertragbare Infektionen. Journal of the German Society of Dermatology 2019; 17: 287-317
• 49 Nandwani R, Evans D. Are you sure it’s syphilis? A review of false positive serology. International Journal of STD & AIDS 1995; 6: 241-248
• 50 Deutsche-STI-Gesellschaft. Leitlinie Diagnostik und Therapie der Syphilis. AWMF online 2020; 1–83 Im Internet. https://www.awmf.org/uploads/tx_szleitlinien/059–002l_S2k_Diagnostik_Therapie_Syphilis_2020_06_1_01.pdf
• 51 Workowski KA, Bolan GA. Sexually Transmitted Diseases Tretment Guidelines, 2015. MMWR Recomm Rep 2015; 64: 1-137
• 52 World Health Organization. WHO Guidelines for the Treatment of Treponema pallidum (syphilis). Geneva,; 2016
• 53 Deutsche Gesellschaft für Neurologie. Neurosyphilis – S1 Leitlinie. AWMF online 2020; 1–38 Im Internet. https://dgn.org/wp-content/uploads/2013/01/030101_LL_Neurosyphilis_2020.pdf
• 54 Stamm L V. Global Challenge of Antibiotic-Resistant Treponema pallidum. Antimicrobial Agents and Chemotherapy 2010; 54: 583-589
• 55 Giacani L, Ciccarese G, Puga-Salazar C. et al. Enhanced molecular typing of treponema pallidum subspecies pallidum strains from 4 Italian hospitals shows geographical differences in strain type heterogeneity, widespread resistance to macrolides, and lack of mutations associated with doxycycline resist. Sexually Transmitted Diseases 2018; 45: 237-242
• 56 Butler T. The Jarisch-Herxheimer Reaction after antibiotic treatment of spirochetal infections: A review of recent cases and our understanding of pathogenesis. The American Journal of tropical medicine and hygiene 2017; 96: 46-52
• 57 Teklu B, Habte-Michael A, Warrell DA. et al. Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever. The Lancet 1983; 321: 835-839
• 58 Dobbin JM, Perkins JH. Otosyphilis and hearing loss: Response to Penicillin and steroid therapy. The Laryngoscope 1983; 93: 1540-1543
• 59 Yimtae K, Srirompotong S, Lertsukprasert K. Otosyphilis: A review of 85 cases. Otolaryngology – Head and Neck Surgery 2007; 136: 67-71
• 60 Steckelberg JM, McDonald TJ. Otologic involvement in late syphilis. The Laryngoscope 1984; 94: 753-757
• 61 Wong RT, Lepore ML, Burch GR. et al. Luetic Hearing Loss. The Laryngoscope 1977; 87: 1765-1769
• 62 Hendershot EL. Luetic Deafness. The Laryngoscope 1973; 83: 865-870
• 63 Pulec J. Meniere’s disease: results of a two and one-half-year study of etiology, natural history and results of treatment. The Laryngoscope 1972; 82: 1703-1715
• 64 Hahn RD, Rodin P, Haskins HL. Treatment of neural deafness with prednisone. Journal of Chronic Diseases 1962; 15: 395-409
• 65 Gleich LL, Linstrom CJ, Kimmelman CP. Otosyphilis: A Diagnostic and Therapeutic Dilemma. The Laryngoscope 1992; 102: 1255-1259
• 66 Smith ME, Canalis RF. Otologic Manifestations of AIDS: The Otosyphilis Connection. The Laryngoscope 1989; 99: 365-372
• 67 Chotmongkol V, Khamsai S, Vatanasapt P. et al. Penicillin G sodium as a treatment of otosyphilis with hearing loss. Antibiotics 2019; 8: 4-8
• 68 Bigelow DC, Kay DJ, Rafter KO. et al. Facial nerve stimulation from cochlear implants. American Journal of Otology 1998; 19: 163-169
• 69 Karmody C, Schuhknecht H. Deafness in congenital syphilis. Archives of Otolaryngology 1966; 83: 18-27
• 70 Komamura H, Nakamura T, Kobayashi J. et al. Early neurosyphilis presenting with multiple cranial nerve palsies: A case report of management by combined penicillin-corticosteroid treatment. Journal of Infection and Chemotherapy 2019; 25: 362-364
• 71 Bolan RK, Beymer MR, Weiss RE. et al. Doxycycline Prophlaxis to Reduce Incident Syphilis among HIV-Infected Men who have Sex with Men who Continue to Engage in High Risk Sex: A Randomized, Controlled Pilot Study. Sexually Transmitted Diseases 2015; 42: 98-103
• 72 Molina J-M, Charreau I, Chidiac C. et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18: 308-317